Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taipei 105, Taiwan.
College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Medicina (Kaunas). 2021 Nov 17;57(11):1261. doi: 10.3390/medicina57111261.
We studied whether the extent of exertional oxygen desaturation and emphysema could cause greater mortality in COPD and asthma independent of airflow obstruction. We performed a 5-year longitudinal observational study in COPD and asthma patients who matched for airflow obstruction severity. All subjects performed a 6-min walk test (6MWT) and high-resolution computed tomography (HRCT) and followed spirometry and oxygen saturation (SpO) during the 6MWT every 3-6 months. Overall survival was recorded. Cumulative survival curves were performed according to the Kaplan-Meier method and compared with the log-rank test. The COPD group had higher emphysema scores, higher Δinspiratory capacities (ICs) and lower SpO during the 6MWT, which showed a greater yearly decline in FEV (40.6 mL) and forced vital capacity (FVC) (28 mL) than the asthma group (FEV, 9.6 mL; FVC, 1.2 mL; < 0.05). The emphysema-predominant COPD group had an accelerated annual decline in lung function and worse survival. The nadir SpO ≤ 80% and a higher emphysema score were the strong risk factors for mortality in COPD patients. The greater structural changes with a higher emphysema score and greater desaturation during the 6MWT in COPD may contribute to worse yearly decline in FEV and higher five-year mortality than in asthma patients with a similar airflow obstruction. The lowest SpO ≤ 80% during the 6MWT and emphysema-predominant COPD were the strong independent factors for mortality in chronic obstructive airway disease patients.
我们研究了在 COPD 和哮喘患者中,运动性低氧饱和度和肺气肿的严重程度是否独立于气流阻塞导致更大的死亡率。我们对 COPD 和哮喘患者进行了一项为期 5 年的纵向观察性研究,这些患者的气流阻塞严重程度相匹配。所有患者均进行了 6 分钟步行测试(6MWT)和高分辨率计算机断层扫描(HRCT),并在 6MWT 期间每 3-6 个月进行肺功能和血氧饱和度(SpO2)监测。记录总体生存率。根据 Kaplan-Meier 方法绘制累积生存率曲线,并与对数秩检验进行比较。COPD 组的肺气肿评分较高,在 6MWT 中吸气容量(IC)较高,SpO2 较低,与哮喘组相比,FEV1(40.6mL)和用力肺活量(FVC)(28mL)的年下降幅度更大(FEV1,9.6mL;FVC,1.2mL;<0.05)。肺气肿为主的 COPD 组肺功能下降更快,生存率更差。6MWT 时 SpO2 最低值≤80%和肺气肿评分较高是 COPD 患者死亡的强危险因素。COPD 患者在 6MWT 期间存在更大的结构性变化,肺气肿程度更高,低氧饱和度更严重,这可能导致其 FEV1 年下降幅度大于具有相似气流阻塞的哮喘患者,生存率更差。6MWT 时最低 SpO2≤80%和以肺气肿为主的 COPD 是慢性阻塞性气道疾病患者死亡的强独立因素。